FDA Panel Favors Device to Boost Lung Transplant Success [1]
On March 20, 2014, a panel of the FDA gave unanimous approval for use of an ex-vivo perfusion system for improving the quality of explanted lungs prior to transplantation. If this recommendation is followed by the FDA, such devices could be used clinically under IRB protocols.
Source name:
MedPage Today
Resource link:
Taxonomy2018 vocabulary term reference:
Lung Transplant [5]